<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<ReleaseSet Dated="2016-07-04" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" Type="full" xsi:noNamespaceSchemaLocation="http://ftp.ncbi.nlm.nih.gov/pub/clinvar/xsd_public/clinvar_public_1.35.xsd">

  <ClinVarSet ID="10313021">
  <RecordStatus>current</RecordStatus>
  <Title>NM_000551.3(VHL):c.405A&gt;C (p.Leu135Phe) AND Hemangioblastoma, sporadic cerebellar</Title>
  <ReferenceClinVarAssertion DateCreated="2012-08-13" DateLastUpdated="2016-02-17" ID="59810">
    <ClinVarAccession Acc="RCV000002307" Version="2" Type="RCV" DateUpdated="2016-02-17"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="1994-09-15">
      <ReviewStatus>no assertion criteria provided</ReviewStatus>
      <Description>Pathogenic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ObservedIn>
      <Sample>
        <Origin>germline</Origin>
        <Species TaxonomyId="9606">human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData ID="9730434">
        <Attribute Type="Description">In a sporadic case of cerebellar hemangioblastoma, Kanno et al. (1994) identified a missense mutation in exon 2 of the VHL gene: a 618A-C transversion, resulting in a leu135-to-phe substitution.</Attribute>
        <Citation Type="general">
          <ID Source="PubMed">8069849</ID>
        </Citation>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant" ID="2221">
      <Measure Type="single nucleotide variant" ID="17260">
        <Name>
          <ElementValue Type="Preferred">NM_000551.3(VHL):c.405A&gt;C (p.Leu135Phe)</ElementValue>
        </Name>
        <AttributeSet>
          <Attribute Type="HGVS, coding, LRG" Change="c.405A&gt;C">LRG_322t1:c.405A&gt;C</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, coding, RefSeq" Change="c.341-3209A&gt;C">NM_198156.2:c.341-3209A&gt;C</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, coding, RefSeq" Change="c.405A&gt;C">NM_000551.3:c.405A&gt;C</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, LRG" Change="g.9944A&gt;C">LRG_322:g.9944A&gt;C</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, RefSeqGene" Change="g.9944A&gt;C">NG_008212.3:g.9944A&gt;C</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level" Change="g.10146578A&gt;C" integerValue="38">NC_000003.12:g.10146578A&gt;C</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level, previous" Change="g.10188262A&gt;C" integerValue="37">NC_000003.11:g.10188262A&gt;C</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, protein" Change="p.Leu135Phe">LRG_322p1:p.Leu135Phe</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, protein, RefSeq" Change="p.Leu135Phe">NP_000542.1:p.Leu135Phe</Attribute>
          <XRef Type="rs" ID="119103278" DB="dbSNP"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="MolecularConsequence">intron variant</Attribute>
          <XRef ID="SO:0001627" DB="Sequence Ontology"/>
          <XRef ID="NM_198156.2:c.341-3209A&gt;C" DB="RefSeq"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="MolecularConsequence">missense variant</Attribute>
          <XRef ID="SO:0001583" DB="Sequence Ontology"/>
          <XRef ID="NM_000551.3:c.405A&gt;C" DB="RefSeq"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ProteinChange1LetterCode">L135F</Attribute>
          <XRef Type="Allelic variant" ID="608537.0008" DB="OMIM"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ProteinChange3LetterCode">LEU135PHE</Attribute>
          <XRef Type="Allelic variant" ID="608537.0008" DB="OMIM"/>
        </AttributeSet>
        <CytogeneticLocation>3p25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.28" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="10146578" stop="10146578" display_start="10146578" display_stop="10146578" variantLength="1" referenceAllele="A" alternateAllele="C"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="10188262" stop="10188262" display_start="10188262" display_stop="10188262" variantLength="1" referenceAllele="A" alternateAllele="C"/>
        <MeasureRelationship Type="variant in gene">
          <Name>
            <ElementValue Type="Preferred">von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase</ElementValue>
          </Name>
          <Symbol>
            <ElementValue Type="Preferred">VHL</ElementValue>
          </Symbol>
          <AttributeSet>
            <Attribute dateValue="2012-07-06" Type="Haploinsufficiency">Sufficient evidence for dosage pathogenicity</Attribute>
            <Citation>
              <URL>http://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=VHL</URL>
            </Citation>
          </AttributeSet>
          <AttributeSet>
            <Attribute dateValue="2012-07-06" Type="Triplosensitivity">Little evidence for dosage pathogenicity</Attribute>
            <Citation>
              <URL>http://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=VHL</URL>
            </Citation>
          </AttributeSet>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.28" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="10141634" stop="10153669" display_start="10141634" display_stop="10153669" variantLength="12036" Strand="+"/>
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="10183318" stop="10195353" display_start="10183318" display_stop="10195353" variantLength="12036" Strand="+"/>
          <XRef ID="7428" DB="Gene"/>
          <XRef Type="MIM" ID="608537" DB="OMIM"/>
          <XRef ID="HGNC:12687" DB="HGNC"/>
          <Comment DataSource="NCBI curation" Type="public">This gene is cited in the ACMG recommendations of 2013 (PubMed 23788249) for reporting incidental findings in exons.</Comment>
        </MeasureRelationship>
        <XRef Type="Allelic variant" ID="608537.0008" DB="OMIM"/>
        <XRef Type="rs" ID="119103278" DB="dbSNP"/>
      </Measure>
      <Name>
        <ElementValue Type="Preferred">NM_000551.3(VHL):c.405A&gt;C (p.Leu135Phe)</ElementValue>
      </Name>
    </MeasureSet>
    <TraitSet Type="Disease" ID="573">
      <Trait ID="9770" Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Hemangioblastoma, sporadic cerebellar</ElementValue>
        </Name>
      </Trait>
    </TraitSet>
  </ReferenceClinVarAssertion>
  <ClinVarAssertion ID="22465">
    <ClinVarSubmissionID localKey="608537.0008_HEMANGIOBLASTOMA, SPORADIC CEREBELLAR" submitter="OMIM" submitterDate="2013-04-22" title="VHL, LEU135PHE_HEMANGIOBLASTOMA, SPORADIC CEREBELLAR"/>
    <ClinVarAccession Acc="SCV000022465" Version="1" Type="SCV" OrgID="3" DateUpdated="2015-10-11"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="1994-09-15">
      <ReviewStatus>no assertion criteria provided</ReviewStatus>
      <Description>Pathogenic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ExternalID DB="OMIM" ID="608537.0008" Type="Allelic variant"/>
    <ObservedIn>
      <Sample>
        <Origin>germline</Origin>
        <Species>human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData>
        <Attribute Type="Description">In a sporadic case of cerebellar hemangioblastoma, Kanno et al. (1994) identified a missense mutation in exon 2 of the VHL gene: a 618A-C transversion, resulting in a leu135-to-phe substitution.</Attribute>
        <Citation>
          <ID Source="PubMed">8069849</ID>
        </Citation>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant">
      <Measure Type="Variation">
        <Name>
          <ElementValue Type="Preferred">VHL, LEU135PHE</ElementValue>
        </Name>
        <AttributeSet>
          <Attribute Type="NonHGVS">LEU135PHE</Attribute>
        </AttributeSet>
        <MeasureRelationship Type="variant in gene">
          <Symbol>
            <ElementValue Type="Preferred">VHL</ElementValue>
          </Symbol>
        </MeasureRelationship>
        <XRef DB="OMIM" ID="608537.0008" Type="Allelic variant"/>
      </Measure>
    </MeasureSet>
    <TraitSet Type="Disease">
      <Trait Type="Disease">
        <Name>
          <ElementValue Type="Preferred">HEMANGIOBLASTOMA, SPORADIC CEREBELLAR</ElementValue>
        </Name>
      </Trait>
    </TraitSet>
  </ClinVarAssertion>
</ClinVarSet>
</ReleaseSet>